166 related articles for article (PubMed ID: 29584707)
1. MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
Azer SA
J Clin Med; 2018 Mar; 7(4):. PubMed ID: 29584707
[TBL] [Abstract][Full Text] [Related]
2. Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.
Ranjan A; Bera K; Iwakuma T
Hepatoma Res; 2016; 2():114-121. PubMed ID: 28944296
[TBL] [Abstract][Full Text] [Related]
3. The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.
Cao H; Chen X; Wang Z; Wang L; Xia Q; Zhang W
Cell Death Discov; 2020; 6():53. PubMed ID: 32595984
[TBL] [Abstract][Full Text] [Related]
4. Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy.
Wang W; Zafar A; Rajaei M; Zhang R
Cells; 2020 May; 9(5):. PubMed ID: 32397368
[TBL] [Abstract][Full Text] [Related]
5. MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53.
Wang Y; Wang G; Tan X; Ke K; Zhao B; Cheng N; Dang Y; Liao N; Wang F; Zheng X; Li Q; Liu X; Liu J
Oncogenesis; 2019 Nov; 8(12):67. PubMed ID: 31732712
[TBL] [Abstract][Full Text] [Related]
6. MDM2-p53 Interaction Inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present).
Rusiecki R; Witkowski J; Jaszczewska-Adamczak J
Recent Pat Anticancer Drug Discov; 2019; 14(4):324-369. PubMed ID: 31642413
[TBL] [Abstract][Full Text] [Related]
7. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.
Qin JJ; Li X; Hunt C; Wang W; Wang H; Zhang R
Genes Dis; 2018 Sep; 5(3):204-219. PubMed ID: 30320185
[TBL] [Abstract][Full Text] [Related]
8. Regulation of apoptosis by ubiquitination in liver cancer.
Li Y; Zhu J; Yu Z; Zhai F; Li H; Jin X
Am J Cancer Res; 2023; 13(10):4832-4871. PubMed ID: 37970337
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA LINC00342 Promotes the Proliferation, Invasion, and Migration of Primary Hepatocellular Carcinoma Cells by Regulating the Expression of miRNA-19a-3p, miRNA-545-5p, and miRNA-203a-3p.
Yao ZX; Tu JH; Liu YL; Xue XF; Qin L
Biochem Genet; 2024 Apr; 62(2):675-697. PubMed ID: 37395850
[TBL] [Abstract][Full Text] [Related]
10. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.
Choudhary HB; Mandlik SK; Mandlik DS
World J Gastrointest Pathophysiol; 2023 Jun; 14(3):46-70. PubMed ID: 37304923
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential prognostic biomarkers for hepatocellular carcinoma.
Zhang L; Yuan L; Li D; Tian M; Sun S; Wang Q
J Gastrointest Oncol; 2022 Apr; 13(2):812-821. PubMed ID: 35557563
[TBL] [Abstract][Full Text] [Related]
12. MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A.
Ayesha M; Majid A; Zhao D; Greenaway FT; Yan N; Liu Q; Liu S; Sun MZ
J Adv Res; 2022 Feb; 36():147-161. PubMed ID: 35127170
[TBL] [Abstract][Full Text] [Related]
13. The Nuclear Farnesoid X Receptor Reduces p53 Ubiquitination and Inhibits Cervical Cancer Cell Proliferation.
Huang X; Wang B; Chen R; Zhong S; Gao F; Zhang Y; Niu Y; Li C; Shi G
Front Cell Dev Biol; 2021; 9():583146. PubMed ID: 33889569
[TBL] [Abstract][Full Text] [Related]
14. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches.
Farzaneh Z; Vosough M; Agarwal T; Farzaneh M
Cancer Cell Int; 2021 Apr; 21(1):208. PubMed ID: 33849569
[TBL] [Abstract][Full Text] [Related]
15. MTA1 Promotes Hepatocellular Carcinoma Progression by Downregulation of DNA-PK-Mediated H1.2
Li YH; Zhong M; Zang HL; Tian XF
Front Oncol; 2020; 10():567. PubMed ID: 32435614
[TBL] [Abstract][Full Text] [Related]
16. Degradation of proteins by PROTACs and other strategies.
Wang Y; Jiang X; Feng F; Liu W; Sun H
Acta Pharm Sin B; 2020 Feb; 10(2):207-238. PubMed ID: 32082969
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics.
Xu X; Li S; Cui X; Han K; Wang J; Hou X; Cui L; He S; Xiao J; Yang Y
Front Oncol; 2019; 9():1406. PubMed ID: 31921663
[TBL] [Abstract][Full Text] [Related]
18. Mdm2 is a target and mediator of IRP2 in cell growth control.
Zhang J; Kong X; Zhang Y; Sun W; Xu E; Chen X
FASEB J; 2020 Feb; 34(2):2301-2311. PubMed ID: 31907996
[TBL] [Abstract][Full Text] [Related]
19. Fine tuning of p53 functions between normal and leukemic cells: a new strategy for the treatment of chronic lymphocytic leukemia.
Stankovic T
Haematologica; 2019 Dec; 104(12):2332-2334. PubMed ID: 31787615
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
